Free Trial

Grainger (GRI) Competitors

Grainger logo
GBX 188.72 +0.92 (+0.49%)
As of 12:18 PM Eastern

GRI vs. SOPH, ITH, HCM, INDV, SLS, ERGO, SLN, AMYT, BMY, and GPH

Should you be buying Grainger stock or one of its competitors? The main competitors of Grainger include Sophos Group plc (SOPH.L) (SOPH), Ithaca Energy (ITH), HUTCHMED (HCM), Indivior (INDV), Standard Life UK Smaller Companies Trust (SLS), Ergomed (ERGO), Silence Therapeutics (SLN), Amryt Pharma (AMYT), Bloomsbury Publishing (BMY), and Global Ports (GPH). These companies are all part of the "pharmaceutical products" industry.

Grainger vs. Its Competitors

Sophos Group plc (SOPH.L) (LON:SOPH) and Grainger (LON:GRI) are both pharmaceutical products companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, profitability, earnings, valuation, institutional ownership, analyst recommendations and media sentiment.

Sophos Group plc (SOPH.L) has a net margin of 0.00% compared to Grainger's net margin of -0.40%. Sophos Group plc (SOPH.L)'s return on equity of 0.00% beat Grainger's return on equity.

Company Net Margins Return on Equity Return on Assets
Sophos Group plc (SOPH.L)N/A N/A N/A
Grainger -0.40%-0.06%2.14%

Grainger has a consensus price target of GBX 317.50, indicating a potential upside of 68.24%. Given Grainger's stronger consensus rating and higher probable upside, analysts clearly believe Grainger is more favorable than Sophos Group plc (SOPH.L).

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sophos Group plc (SOPH.L)
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Grainger
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

67.7% of Grainger shares are held by institutional investors. 1.4% of Grainger shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Sophos Group plc (SOPH.L) has higher revenue and earnings than Grainger. Sophos Group plc (SOPH.L) is trading at a lower price-to-earnings ratio than Grainger, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sophos Group plc (SOPH.L)£726.90M0.00N/A£1.70N/A
Grainger£306.10M4.55-£1.11M£0.151,283.81

In the previous week, Grainger had 1 more articles in the media than Sophos Group plc (SOPH.L). MarketBeat recorded 1 mentions for Grainger and 0 mentions for Sophos Group plc (SOPH.L). Sophos Group plc (SOPH.L)'s average media sentiment score of 0.00 equaled Grainger'saverage media sentiment score.

Company Overall Sentiment
Sophos Group plc (SOPH.L) Neutral
Grainger Neutral

Sophos Group plc (SOPH.L) pays an annual dividend of GBX 0.04 per share. Grainger pays an annual dividend of GBX 0.08 per share and has a dividend yield of 0.0%. Sophos Group plc (SOPH.L) pays out 2.4% of its earnings in the form of a dividend. Grainger pays out 51.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Summary

Grainger beats Sophos Group plc (SOPH.L) on 9 of the 14 factors compared between the two stocks.

Get Grainger News Delivered to You Automatically

Sign up to receive the latest news and ratings for GRI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GRI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GRI vs. The Competition

MetricGraingerReal Estate Services IndustryReal Estate SectorLON Exchange
Market Cap£1.39B£1.78B£1.76B£2.58B
Dividend Yield4.15%5.16%6.83%5.30%
P/E Ratio1,283.81375.09259.385,404.14
Price / Sales4.55209.39618.4996,701.95
Price / Cash19.2219.4866.7927.93
Price / Book0.732.201.328.78
Net Income-£1.11M-£411.39M-£120.13M£5.89B
7 Day Performance-1.61%-0.39%0.40%0.56%
1 Month Performance-6.97%-0.97%0.50%44.71%
1 Year Performance-22.02%1.61%6.03%174.03%

Grainger Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GRI
Grainger
2.8403 of 5 stars
GBX 188.72
+0.5%
GBX 317.50
+68.2%
-22.4%£1.39B£306.10M1,283.81372Positive News
Dividend Increase
SOPH
Sophos Group plc (SOPH.L)
N/AN/AN/AN/A£2.99B£726.90M341.41520
ITH
Ithaca Energy
N/AGBX 180.80
-2.6%
N/A+86.3%£2.98B£2.59B-1,705.66220Positive News
HCM
HUTCHMED
N/AGBX 235.59
+0.2%
N/A-0.8%£2.02B£602.20M444.501,760
INDV
Indivior
1.9568 of 5 stars
GBX 1,238
+1.6%
GBX 1,800
+45.4%
+66.0%£1.93B£1.40B-1,026.481,000Gap Up
High Trading Volume
SLS
Standard Life UK Smaller Companies Trust
N/AN/AN/AN/A£715.41M£222.48M3.3710
ERGO
Ergomed
N/AN/AN/AN/A£701.00M£152.09M4,641.386
SLN
Silence Therapeutics
N/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading Volume
AMYT
Amryt Pharma
N/AN/AN/AN/A£457.11M£210.24M-4.33290Gap Down
BMY
Bloomsbury Publishing
2.2854 of 5 stars
GBX 501.56
+1.0%
GBX 825
+64.5%
-23.3%£408.25M£361M1,633.2034,300
GPH
Global Ports
N/AN/AN/AN/A£231.21M£193.58M30,000.0020

Related Companies and Tools


This page (LON:GRI) was last updated on 9/15/2025 by MarketBeat.com Staff
From Our Partners